Pesch Michael Robert sold $2.1M of AJG

Pesch Michael Robert (Vice President) sold 7,520 shares of Arthur J. Gallagher & Co. (AJG) at $282.30 ($2.12M total) on 2026-11-13.

Original reporting
SEC EDGAR · Pesch Michael Robert
Published Nov 17, 2026, 12:52 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 17, 2026, 12:56 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$AJG
Neutral
high confidence
Mentioned
$AJG
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AJGNeutralLow
01

Why it matters

The disclosure updates AJG’s insider ownership record but does not, by itself, change operating outlook, valuation drivers, or risk factors.

02

Market read

Traders may note the insider sale, but absent any accompanying corporate event, it is unlikely to drive material repricing.

03

What to watch

The sale is described as open-market and not tied to a 10b5-1 plan in the text; without context on diversification or tax planning, the trading signal is weak.

Relevance 6/10Novelty 3/10Timing: filed 2026-11-16, transaction dated 2026-11-13

Background

The filing is an SEC Form 4 insider transaction for Arthur J. Gallagher & Co., reported by VP Michael Robert Pesch.

Company-level read

Ticker impact

$AJGNeutralHigh confidence
Context

Arthur J. Gallagher & Co. disclosed an insider Form 4 showing VP Michael Robert Pesch sold 7,520 shares at $282.3001 on 2026-11-13.

Expected impact

Likely minimal near-term impact, as the filing is a standard insider transaction without a stated fundamental catalyst.

Evidence & confidence

The article provides only an insider sale size and price, with no accompanying company news, guidance change, or regulatory/legal development.

Market effects

No clear sector read-through; this is company-specific insider dealing without broader industry implications.

None indicated.

None indicated.

Counterpoint

Insider sales can sometimes precede negative developments, but this filing includes no new company-specific information to support that inference.

Key entities

  • Arthur J. Gallagher & Co.

    US-listed insurance brokerage company (AJG) subject of the insider Form 4 disclosure.

  • Michael Robert Pesch

    Vice President who sold shares via an open-market transaction.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AJGMed

Why is Arthur J Gallagher stock sliding today?

Arthur J. Gallagher & Co. (AJG) stock fell 0.7% in pre-market trading after BMO Capital and Citi downgraded it to Market Perform and Neutral, respectively, citing valuation concerns. Both firms raised their price targets, with Citi setting it at $300. The stock trades near its 52-week high of $281.53. Insider selling and a risk-averse market also contributed to the decline. Jefferies and Wells Fargo maintained bullish outlooks with higher targets.

$AJGMed

BMO downgrades Arthur J. Gallagher stock rating on valuation

BMO downgraded Arthur J. Gallagher (NYSE:AJG) to Market Perform, raising its price target to $295. The firm cited valuation and AI-related market pressures. AJG's Q3 2026 earnings showed a revenue miss but a 25% net earnings growth. Analysts from Goldman Sachs and Keefe, Bruyette & Woods maintained positive outlooks with targets of $296 and $275, respectively.

$AJGMedAI 8/10

Arthur J. Gallagher & Co (AJG) (Q3 2026) Earnings Call Highlights: 26 Straight Quarters

Arthur J. Gallagher & Co reported Q3 2026 revenue growth of 18%, with net earnings and adjusted EBITDAC up 25%. Brokerage revenues rose 19%, while Risk Management grew 14%. M&A pipeline includes 30 term sheets for $300M in annualized revenue. Challenges include property premium declines and slower Employee Benefits growth. Management expects steady margin expansion and synergies from AssuredPartners.

$AJGMed

Goldman Sachs reiterates Arthur J. Gallagher stock rating on in-line Q3 results

Goldman Sachs maintained a Buy rating and $296 price target on Arthur J. Gallagher (AJG) after Q3 results. Adjusted EPS matched estimates at $3.00, but revenue missed expectations. Goldman lowered 2027 Brokerage growth estimate to 4.5% and adjusted revenue expectations. AJG's stock trades near its 52-week high with a P/E ratio of 44.58. Keefe, Bruyette & Woods raised its price target to $275, citing higher adjusted EBITDAC margins.

$AJGMed

Gallagher’s 5% organic growth looks modest - until you compare it with the competition

Arthur J. Gallagher & Co. reported 5% organic growth in Q3, with revenues of $3.93B and adjusted EPS of $3.00. CEO J. Patrick Gallagher Jr. highlighted the strength of their diversified model. Compared to peers, Gallagher's growth appears modest, but its focus on broking may be advantageous in a softening market. The company completed five acquisitions in Q3, adding $102M in annualized revenues.